Frontofacionasal dysplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1791OMIM:229400Q75.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Frontofacionasal dysplasia (also known as frontofacionasal dysostosis) is an extremely rare congenital malformation syndrome primarily affecting the development of the face, skull, and nose. It was first described by Gollop in 1981. The condition is characterized by a distinctive combination of craniofacial anomalies including blepharophimosis (narrowing of the eye opening), S-shaped palpebral fissures, lagophthalmos (inability to fully close the eyelids), eyelid colobomas, midface hypoplasia, a broad nasal bridge with bifid nose or midline nasal cleft, and cranium bifidum occultum (a defect in the skull bones). Additional features may include hypertelorism (widely spaced eyes), lip pits, cleft lip and/or palate, and anterior cranium bifidum. The facial features are typically evident at birth. The condition primarily affects the craniofacial skeletal system, the eyes, and the nasal structures. Some patients may also present with lipomas or dermoid cysts in the frontonasal region. Intelligence is generally reported as normal in affected individuals, though the severity of structural anomalies can vary. Only a very small number of cases have been reported in the medical literature worldwide, making it one of the rarest craniofacial dysplasias known. There is no specific cure for frontofacionasal dysplasia. Management is supportive and symptomatic, typically involving a multidisciplinary team including craniofacial surgeons, ophthalmologists, and otolaryngologists. Surgical interventions may be required to correct cleft lip/palate, nasal deformities, eyelid abnormalities, and skull defects. Treatment is individualized based on the specific malformations present in each patient, and multiple staged surgeries may be necessary throughout childhood.

Also known as:

Clinical phenotype terms— hover any for plain English:

Bifid nasal tipHP:0000456Upper eyelid colobomaHP:0000636Brushfield spotsHP:0001088Limbal dermoidHP:0001140Tessier cleftHP:0002006
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Frontofacionasal dysplasia.

View clinical trials →

No actively recruiting trials found for Frontofacionasal dysplasia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Frontofacionasal dysplasia community →

No specialists are currently listed for Frontofacionasal dysplasia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Frontofacionasal dysplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Frontofacionasal dysplasiaForum →

No community posts yet. Be the first to share your experience with Frontofacionasal dysplasia.

Start the conversation →

Latest news about Frontofacionasal dysplasia

No recent news articles for Frontofacionasal dysplasia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Frontofacionasal dysplasia

What is Frontofacionasal dysplasia?

Frontofacionasal dysplasia (also known as frontofacionasal dysostosis) is an extremely rare congenital malformation syndrome primarily affecting the development of the face, skull, and nose. It was first described by Gollop in 1981. The condition is characterized by a distinctive combination of craniofacial anomalies including blepharophimosis (narrowing of the eye opening), S-shaped palpebral fissures, lagophthalmos (inability to fully close the eyelids), eyelid colobomas, midface hypoplasia, a broad nasal bridge with bifid nose or midline nasal cleft, and cranium bifidum occultum (a defect i

How is Frontofacionasal dysplasia inherited?

Frontofacionasal dysplasia follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Frontofacionasal dysplasia typically begin?

Typical onset of Frontofacionasal dysplasia is neonatal. Age of onset can vary across affected individuals.